Cellares raises $255M as it boosts its own manufacturing efforts
Cellares, which is known for producing the technology used in cell therapy manufacturing, has raised $255 million in a Series C as it aims to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
